Top 2-3 execution priorities and the biggest risk among patient demand shifts, regulatory changes or competitive pressures?

Satish outlined three priorities: transforming the India TPA business via technology, converting the technology pipeline into growth and margin, and expanding the international business. On risk, he did not name a single biggest risk and instead argued the company's AI-led platform aligns with IRDAI's policyholder-protection intent.

Key financial risks and measures on margins, cash flow and balance sheet strength?

Sandeep Daga said the first priority is completing Paramount integration, which has already driven 330 bps margin improvement over four quarters; DSOs improved 4.5% YoY despite a higher receivable base, with continued focus on efficiency and technology deployment.

How does working capital behave in government business, and can FY27 be a record profit with a return to 23% EBITDA margins?

Satish said government business is margin accretive with safe state/central government collections and no elongation of consolidated DSOs; on margin, he said the immediate goal is to finish Paramount integration and get back toward the pre-Paramount margin through FY27, without giving explicit adjusted EBITDA guidance.

How should investors interpret retail trajectory when traditional TPA appears plateaued but technology is growing?

Satish explained the TPA model is not going away and that reporting understates retail participation because platform-led work for insurers is not captured as TPA revenue; he suggested evaluating retail market access through retail plus technology revenue.

Overall business growth expectation for the company, possibly at least mid-teens?

Satish reiterated that core group and retail should grow at par or faster than the market, technology should grow faster, and international Q1 is not indicative of its capability; he did not commit to a consolidated mid-teens growth number.

Organic growth in the old group TPA business ex-Paramount and how the first outcomes-based contract works?

Satish said retention was about 90%, same-store growth was holding at about 8% and new business has seasonality, but he could not break out Medi Assist and Paramount separately; the outcomes-based contract question was deferred when the moderator moved the queue.

HITPA risk from PSU insurers moving TPA in-house, plus depreciation bifurcation?

Satish declined to comment specifically on HITPA and emphasised policyholder choice of TPA and Medi Assist's right to win; on retention, he attributed 90% to onboarding challenges, high base and rationalisation; depreciation bifurcation was deferred offline.

NPS Swasthya relationship and long-term potential, and insurer pushback on technology platform adoption?

Satish explained Medi Assist acts as the health benefits administrator connecting members, CRAs, pension funds, insurers and payments; the scheme is early-stage but could extend to a substantial part of NPS membership. On insurer adoption, he reframed pushback as integration effort and said there are conversations, contracts and POCs running with half of the insurers.

Medi Assist Ser. Q1 FY27 Earnings Call — Analysis (NSE: MEDIASSIST)

Medi Assist Q1 FY27 revenue grew 24.1% YoY to ₹236.5 Cr with operating EBITDA margin expanding to 20.3%, while Paramount integration nears completion and the technology/international platforms begin contributing.

14 Aug 2026 · Analysis by Alpha Inflection

Result quality: strong — Earnings grew. Management sentiment: optimistic.

The take

Q1FY27 Total income ₹247 Cr ( +24.9% YoY ) . New guidance — FY27 ebitda margin recovery 22% / 23% . New story: Paramount integration margin recovery .

Results

Q1FY27 operating revenue was ₹236.5 Cr, +24.1% YoY; operating EBITDA was ₹48 Cr, +14.3% YoY with an operating EBITDA margin of 20.3%; reported PAT was ₹27.6 Cr, including a ₹3.1 Cr one-time derivative gain, with adjusted PAT at ₹24.5 Cr.

Financial highlights

Medi Assist Ser. Q1 FY27 reported figures
Metric	Value	Change	Basis
Total income	₹247 Cr	+24.9%	yoy · Q1FY27
Operating revenue from contracts	₹236.5 Cr	+24.1%	yoy · Q1FY27 · Excludes other income
Operating EBITDA	₹48 Cr	+14.3%	yoy · Q1FY27 · Excludes other income; 20.3% margin on operating revenue
Operating EBITDA margin	20.3%		sequential · Q1FY27 · Sequential improvement from 17.1% in Q2FY26, 18.6% in Q3FY26 and 19.9% in Q4FY26
Reported PAT	₹27.6 Cr		none · Q1FY27 · Includes one-time derivative gain of ₹3.1 Cr on noncontrolling interest acquisition
Adjusted PAT	₹24.5 Cr		none · Q1FY27 · Excluding one-time derivative gain of ₹3.1 Cr
Group segment revenue	₹166 Cr	+25.5%	yoy · Q1FY27 · 70.2% of operating revenue
Retail TPA segment revenue	₹23.4 Cr	+13.1%	yoy · Q1FY27 · 9.9% of operating revenue
Government segment revenue	₹28.5 Cr	+35.3%	yoy · Q1FY27 · 12% of operating revenue
International segment revenue	₹10.1 Cr	-5.2%	yoy · Q1FY27 · 4.3% of operating revenue
Technology SaaS revenue	₹7.8 Cr	+55.5%	yoy · Q1FY27 · 3.3% of operating revenue
Free cash position	₹245.5 Cr		point_in_time · Q1FY27 · As on Q1FY27
Net worth	₹884.1 Cr		point_in_time · Q1FY27 · As on Q1FY27
Contract liability	₹337.4 Cr		point_in_time · Q1FY27 · As on Q1FY27

Guidance

Management expects remaining Paramount claims and operations to migrate to the Medi Assist stack in Q2FY27, with the PHS retention drag normalising and EBITDA margins recovering toward pre-Paramount 22-23% levels through the end of FY27.

What management committed to

we target a full [migration] of the balance [Paramount] claims and [Paramount] operations to move to [Medi Assist's] MAtrix stack within Q2 FY27. — Q2FY27
we expect this near-term PHS retention drag will get fully normalized through FY27. — FY27
our immediate order of the day is to finish the remaining activities in the Paramount integrations and get back to that [EBITDA margin of around 22% reported in Q1 FY26 before Paramount integration / 23% historical IPO margin] through FY27 towards the end of FY27. — 22% / 23%, FY27
On the core business, [Medi Assist] will continue to grow at par or faster than the market in the group and retail segments. — at par or faster than the market, FY27
As some of these other [international] projects kick in, we expect to see the [international business] growth coming back or improving. — FY27
[Medi Assist's] MAtrix implementation at Star crossed the 90% mark and is well on its way to completing pretty soon. — crossed the 90% mark, pretty soon

Key themes

Paramount integration completion and platform monetisation

How the narrative shifted

Paramount integration margin recovery: Management frames the Paramount integration as logically complete with only the final migration pending, positioning the associated margin and retention drag as temporary and normalising through FY27.
Tech platform monetisation: The technology stack is being repositioned from an internal TPA efficiency tool into standalone SaaS-style solutions for insurers, with disclosed customer counts and a first outcomes-based contract.
International expansion and Thailand go-live: Mayfair is being built as the dedicated international growth vehicle, with the first Thailand deployment live even though Q1 revenue fell from softer travel-related volumes.
Core TPA market leadership: The core India TPA franchise is presented as a market leader with strong group premium growth and share, though retention is temporarily below its historical 93-94% range.
Government segment growth: Government is framed as an opportunistic but margin-accretive segment with safe collections, not driving a working-capital problem despite its faster growth.
Leadership and governance transition: The transition of Dr Chhatwal to Non-Executive Chairman is positioned as best-practice governance separation rather than a change in strategy or operational control.
AI-driven operational efficiency: AI deployments are highlighted through concrete operating metrics such as five-minute pre-authorisations, 0-wait discharge and fraud savings, reinforcing the platform's value proposition.

Operational commentary

Paramount integration nearing completion: management called it a logical closure, with over 95% of group claims and over 80% of retail claims migrated to MAtrix at end-Q1FY27; full balance migration targeted within Q2FY27.
Core India group TPA remains the dominant franchise: group premiums grew 29.5% YoY, group market share was 37.6%, and retention was 90.2%, with the retention drag attributed to post-acquisition Paramount transition, portfolio rationalisation and higher base effect.
Technology platform gained commercial traction: technology SaaS revenue grew 55.5% YoY to ₹7.8 Cr, 7 insurers are contracted across MAven, MAtrix and Magnum stacks, a first outcomes-based fraud, waste and abuse contract was signed, and the platform delivered ₹183 Cr of fraud savings in Q1.
Retail/hybrid model is expanding beyond traditional TPA: TPA-model retail premiums were ₹521 Cr while platform-administered retail premiums touched ₹4,254 Cr, representing a 29%+ market share; management said retail should be assessed as retail plus technology revenue.
Government business scaled profitably: revenue grew 35.3% YoY to ₹28.5 Cr, serving 31 crore members across 12 states and 4 union territories; management stated government business is margin accretive, collections are safe and it does not elongate consolidated DSOs.
International business had a soft quarter but hit a milestone: Mayfair ownership increased to 91.75% post-Q1, the first technology deployment went live in Thailand from 1 July 2026, and Q1 international revenue declined 5.2% YoY on student, leisure and marine volume softness.
Leadership and governance transition: Dr Vikram Chhatwal will transition from Executive Chairman to Non-Executive Non-Independent Chairman after the 8 September AGM; Gaurav Bhatnagar joined as Chief TPA Officer and Nikhil Chopra will lead the international business full-time.

Analyst Q&A

Q. Top 2-3 execution priorities and the biggest risk among patient demand shifts, regulatory changes or competitive pressures?
Satish outlined three priorities: transforming the India TPA business via technology, converting the technology pipeline into growth and margin, and expanding the international business. On risk, he did not name a single biggest risk and instead argued the company's AI-led platform aligns with IRDAI's policyholder-protection intent.
Q. Key financial risks and measures on margins, cash flow and balance sheet strength?
Sandeep Daga said the first priority is completing Paramount integration, which has already driven 330 bps margin improvement over four quarters; DSOs improved 4.5% YoY despite a higher receivable base, with continued focus on efficiency and technology deployment.
Q. How does working capital behave in government business, and can FY27 be a record profit with a return to 23% EBITDA margins?
Satish said government business is margin accretive with safe state/central government collections and no elongation of consolidated DSOs; on margin, he said the immediate goal is to finish Paramount integration and get back toward the pre-Paramount margin through FY27, without giving explicit adjusted EBITDA guidance.
Q. How should investors interpret retail trajectory when traditional TPA appears plateaued but technology is growing?
Satish explained the TPA model is not going away and that reporting understates retail participation because platform-led work for insurers is not captured as TPA revenue; he suggested evaluating retail market access through retail plus technology revenue.
Q. Overall business growth expectation for the company, possibly at least mid-teens?
Satish reiterated that core group and retail should grow at par or faster than the market, technology should grow faster, and international Q1 is not indicative of its capability; he did not commit to a consolidated mid-teens growth number.
Q. Organic growth in the old group TPA business ex-Paramount and how the first outcomes-based contract works?
Satish said retention was about 90%, same-store growth was holding at about 8% and new business has seasonality, but he could not break out Medi Assist and Paramount separately; the outcomes-based contract question was deferred when the moderator moved the queue.
Q. HITPA risk from PSU insurers moving TPA in-house, plus depreciation bifurcation?
Satish declined to comment specifically on HITPA and emphasised policyholder choice of TPA and Medi Assist's right to win; on retention, he attributed 90% to onboarding challenges, high base and rationalisation; depreciation bifurcation was deferred offline.
Q. NPS Swasthya relationship and long-term potential, and insurer pushback on technology platform adoption?
Satish explained Medi Assist acts as the health benefits administrator connecting members, CRAs, pension funds, insurers and payments; the scheme is early-stage but could extend to a substantial part of NPS membership. On insurer adoption, he reframed pushback as integration effort and said there are conversations, contracts and POCs running with half of the insurers.
Q. PSU group PUM growth versus industry and overall group health insurance industry growth?
Satish confirmed overall group health insurance industry growth was about 14%, while the PSU segment was down about 1.5% YoY; Medi Assist improved share of wallet in both PSU and private segments.

View source

Research and educational content only. Not investment advice.